First Clver Leaf Fin (FCLF) 12.27 $FCLF First Clover

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Clver Leaf Fin (FCLF) 12.27 $FCLF

First Clover Leaf Financial Corp. Announces Quarterly Dividend
GlobeNewswire - Wed Jul 27, 12:00PM CDT
First Clover Leaf Financial Corp. (the "Company" (Nasdaq:FCLF) announced the approval by its Board of Directors of a cash dividend on its outstanding common stock of $0.06 per share for the quarter ended June 30, 2016. The dividend will be payable to stockholders of record as of August 19, 2016 and is expected to be paid on August 26, 2016. The Company has 7,005,883 shares of common stock outstanding.
FCLF: 12.27 (-0.12)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of a Class Action Challenging the Fairness of the Sale of First Clover Leaf Financial Corp. to First Mid-Illinois Bancshares Inc. -- FCLF
GlobeNewswire - Wed Jun 15, 1:41PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FMBH: 24.22 (-0.97), FCLF: 12.27 (-0.12)

FIRST CLOVER LEAF FINANCIAL CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Thu May 19, 2:39PM CDT
Rigrodsky & Long, P.A.:
FCLF: 12.27 (-0.12)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of First Clover Leaf Financial Corp.
BusinessWire - Fri May 13, 9:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of First Clover Leaf Financial Corp. ("First Clover Leaf" or "the Company" (Nasdaq: FCLF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to First Mid-Illinois Bancshares Inc. ("First Mid-Illinois".
FCLF: 12.27 (-0.12)

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of First Clover Leaf Financial Corp. to First Mid-Illinois Bancshares Inc.
BusinessWire - Thu May 12, 1:14PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FMBH: 24.22 (-0.97), FCLF: 12.27 (-0.12)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of First Clover Leaf Financial Corp. to First Mid-Illinois Bancshares Inc. is Fair to Shareholders
BusinessWire - Tue May 03, 3:21PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FMBH: 24.22 (-0.97), FCLF: 12.27 (-0.12)

FIRST CLOVER LEAF FINANCIAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of First Clover Leaf Financial Corp.
PR Newswire - Tue May 03, 12:58PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of First Clover Leaf Financial Corp. (NASDAQ: FCLF) ("Clover" or the "Company" to First Mid-Illinois Bancshares, Inc. (NASDAQ: FMBH). Under the terms of the proposed transaction, shareholders of Clover will receive only $12.87 in cash or 0.495 of a share of First Mid common stock, subject to adjustments, for each share of Clover that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
FMBH: 24.22 (-0.97), FCLF: 12.27 (-0.12)

First Clover Leaf Financial Corp. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with First Mid-Illinois Bancshares, Inc.
BusinessWire - Mon May 02, 3:00PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of First Clover Leaf Financial Corp. ("First Clover Leaf" (NASDAQ: FCLF) concerning the merger with First Mid-Illinois Bancshares, Inc. Under the terms of the agreement, valued at approximately $90 million, First Clover Leaf shareholders will only receive either (a) $12.87 or (b) 0.495 shares of common stock, par value $4.00 per share, of First Mid and cash in lieu of fractional shares per share held.
FMBH: 24.22 (-0.97), FCLF: 12.27 (-0.12)

INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of First Clover Leaf Financial Corp. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Mon May 02, 11:57AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of First Clover Leaf Financial Corp. (First Clover Leaf or the "Company" (Nasdaq: FCLF) relating to the proposed buyout of the Company by First Mid-Illinois Bancshares Inc.
FCLF: 12.27 (-0.12)

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of First Clover Leaf Financial Corp. to First Mid-Illinois Bancshares Inc. is Fair to Shareholders
PR Newswire - Mon May 02, 10:35AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
FMBH: 24.22 (-0.97), FCLF: 12.27 (-0.12)

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of First Clover Leaf Financial Corp. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Thu Apr 28, 10:09AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of First Clover Leaf Financial Corp. (First Clover Leaf or the "Company" (Nasdaq: FCLF) relating to the proposed buyout of the Company by First Mid-Illinois Bancshares Inc.
FCLF: 12.27 (-0.12)

First Clover Leaf Financial Corp. Announces Second Quarter Financial Results
GlobeNewswire - Tue Aug 11, 3:30PM CDT
First Clover Leaf Financial Corp. (the "Company" (Nasdaq:FCLF) today reported unaudited net income of $1,212,000 for the second quarter of 2015 compared to $710,000 for the same quarter in 2014, an increase in earnings of $502,000, or 70.7%. Highlighting our strong operating performance was revenue growth from an increase in average loans and an increase in non-interest income. Basic and diluted earnings per share were $0.17 for the second quarter of 2015 compared to $0.10 for the same quarter in 2014. "We are pleased with the increased earnings we are reporting for the second quarter," noted P. David Kuhl, President and CEO. "We continue to execute on our strategic plan and move forward despite the very competitive market conditions in which we operate." While loans, net, decreased to $393,069,712 at June 30, 2015 from $400,904,404 at December 31, 2014, the commercial loan portfolio increased to $147,066,000 at June 30, 2015 from $129,415,000 at December 31, 2014. This represented a 13.6% increase in the commercial loan portfolio. Mr. Kuhl reported, "We are very pleased with our increased commercial activity. Growth in this area highlights our ability to deepen and grow customer relationships, as well as gain new customers and market share."
FCLF: 12.27 (-0.12)

Nasdaq stocks posting largest volume decreases
AP - Wed Mar 25, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
SIBC: 21.40 (+0.05), UNB: 34.57 (-0.29), SSFN: 6.65 (-0.34), OVLY: 9.90 (-0.10), GRIF: 31.91 (-0.28), CWBC: 7.67 (+0.12), SOCB: 14.02 (+0.16), CBIN: 27.37 (+0.16), AMRK: 16.74 (-0.32), CMSB: 13.25 (+0.06), FCLF: 12.27 (-0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 184

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Airtel Money Upgrade Raises the Stakes in East Africa

Updated Category News Views 0

Mobile money lives or dies in the irritating little moments: a transfer that hangs, a menu that makes people punch five buttons too many, a merchant payment that simply will not clear. Airtel Money is attacking that friction in Malawi and Tanzania with an enhanced platform from Comviva, and this is more consequential than the usual software-refresh chest thumping. In...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 197

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 126

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Vusion's 2030 Plan Puts Recurring Revenue First At Scale

Updated Category News Views 20

Shelf labels are not exactly romance, yet Vusion has turned them into a serious growth machine. The 2030 plan is not really about hanging more electronic displays in aisles; it is about making those displays, sensors and store connections produce software and service revenue for years. That is the part of this story worth watching. The Hardware Base Is Becoming the Hook...

Continue Reading
Tim Hortons Bets on ELF Cheer for U.S. Holiday Visits

Updated Category News Views 0

Nothing says holiday restaurant marketing quite like putting spaghetti-shaped whipped topping on hot chocolate and trusting a 2003 movie to do the selling. Tim Hortons is rolling out an ELF-inspired menu at participating U.S. locations starting November 18, 2026, pairing the chain with Warner Bros. Consumer Products and mining Buddy the Elf's sugar-fueled world for a...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 147

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 95

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 67

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading

Top 5 Most Recently Viewed Articles

Dover Set to Release Q2 2025 Earnings; Join the Conference Call

Updated Category News Views 156

Dover Set to Release Q2 2025 Earnings Dover is gearing up to share its financial results for the second quarter of 2025, scheduled for release at approximately 6:00 a.m. Central time on the upcoming Thursday. This significant event marks a crucial moment for shareholders and analysts alike, as they anticipate insights into the company's performance and strategic moves....

Continue Reading
Investigation of ImmunityBio, Inc. and Shareholder Rights

Updated Category News Views 322

Investigation of ImmunityBio, Inc. In recent developments, Bragar Eagel & Squire, P.C., a well-respected law firm specializing in shareholder rights, has launched an investigation regarding ImmunityBio, Inc. (NASDAQ: IBRX). This probe is geared towards looking into potential legal claims on behalf of long-term shareholders, aiming to ensure their interests are safeguarded...

Continue Reading
Norges Bank's Recent Stake Change in Syensqo Explained

Updated Category News Views 279

Norges Bank's Recent Notification Regarding Stake in Syensqo Norges Bank has recently communicated a significant change regarding its participation in Syensqo. This notification, in line with Belgian transparency laws, reveals that Norges Bank has crossed the 3% voting rights threshold, which is vital for all stakeholders. Understanding the Changes in Voting Rights The...

Continue Reading
ZyVersa Therapeutics Marks Progress with Promising Pipeline Updates

Updated Category News Views 232

Key Developments in ZyVersa's Clinical Journey Important Highlights: Announcement of a Phase 2a proof-of-concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 focusing on patients with diabetic kidney disease planned for the first half of 2025. The regulatory framework for VAR 200’s primary indication, focal segmental glomerulosclerosis (FSGS), is set to...

Continue Reading
Bunion Surgery Market Growth and Leading Players Explained

Updated Category News Views 270

Overview of the Bunion Surgery Market The global Bunion Surgery Market is witnessing substantial growth, projected to increase from US$437.8 million in 2023 to an impressive US$606.1 million by 2029, achieving a CAGR of 5.7%. The surge in demand for surgical treatments primarily arises from the rising incidence of bunions, particularly among the aging population who are...

Continue Reading